APA (7th ed.) Citation

Lin, J., Lin, J., Lin, J., Pan, Z., Pan, Z., Pan, Z., . . . Guo, Q. PCSK9 inhibitor alleviates experimental pulmonary fibrosis-induced pulmonary hypertension via attenuating epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling in vivo and in vitro. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Lin, Jiancheng, et al. PCSK9 Inhibitor Alleviates Experimental Pulmonary Fibrosis-induced Pulmonary Hypertension via Attenuating Epithelial-mesenchymal Transition by Suppressing Wnt/β-catenin Signaling in Vivo and in Vitro. Frontiers Media S.A.

MLA (9th ed.) Citation

Lin, Jiancheng, et al. PCSK9 Inhibitor Alleviates Experimental Pulmonary Fibrosis-induced Pulmonary Hypertension via Attenuating Epithelial-mesenchymal Transition by Suppressing Wnt/β-catenin Signaling in Vivo and in Vitro. Frontiers Media S.A.